EX-99.1 2 d366311dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO    News Release

 

NYSE, TSX: NTR

 

February 16, 2022 – all amounts are in US dollars except as otherwise noted

Nutrien Delivers Record Results

and Expects Continued Growth in 2022

SASKATOON, Saskatchewan -- Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2021 results, with net earnings of $1.2 billion ($2.11 diluted net earnings per share). Fourth-quarter adjusted net earnings1 were $2.47 per share and adjusted EBITDA1 was $2.5 billion.

“The advantages of Nutrien’s integrated business were demonstrated in 2021 as we delivered record financial results3 and made significant progress on our long-term strategic targets, including our key sustainability priorities. We utilized the scale and reliability of our world-class supply chain and the strong execution of our teams to ensure customers had the products and services they needed, when they needed them,” commented Ken Seitz, Nutrien’s Interim President and CEO.

“The outlook for global agriculture and crop input markets is very strong and we are well positioned to deliver significant growth in earnings and free cash flow in 2022. We will continue to advance our strategic priorities and maintain a disciplined approach to deploying capital, using our strong financial position to grow the business and return significant cash to shareholders,” added Mr. Seitz.

Highlights:

 

 

Nutrien generated net earnings of $1.2 billion and record adjusted EBITDA of $2.5 billion in the fourth quarter while generating $3.2 billion of net earnings ($5.52 diluted net earnings per share) and record adjusted EBITDA of $7.1 billion ($6.23 adjusted net earnings per share) for the full year of 2021. Cash flow provided by operating activities in the full year was $3.9 billion.

 

 

We prioritized the use of cash in 2021 to strengthen and reposition the balance sheet, reducing our long-term debt by $2.1 billion. We deployed $2.1 billion to dividends and share repurchases in 2021 repurchasing 15 million shares during the year under our normal course issuer bid (NCIB). To date, we have repurchased over 22 million shares under our NCIB program. Nutrien’s Board of Directors approved an increase in the quarterly dividend to $0.48 per share and approved the purchase of up to 10 percent of Nutrien’s outstanding common shares over a one-year period through a NCIB. The NCIB is subject to acceptance by the Toronto Stock Exchange.

 

 

Nutrien issued full-year 2022 adjusted EBITDA and adjusted net earnings per share guidance1 of $10.0 to $11.2 billion and $10.20 to $11.80 per share. Adjusted net earnings per share guidance includes our plans to allocate a minimum of $2 billion to share repurchases in 2022 on a balanced cadence throughout the year.

 

 

Nutrien Ag Solutions (“Retail”) delivered record adjusted EBITDA in the fourth quarter and surpassed $1.9 billion for the full year of 2021. We exceeded nearly all of our 2023 strategic targets including a record 10.9 percent Retail adjusted EBITDA margin2 and increased our proprietary product related gross margin to more than $1 billion in 2021, an increase of 22 percent.

 

 

The reliability and efficiency of our global supply chain and strategic procurement helped drive our Retail normalized comparable store sales1 to 7 percent and Retail adjusted EBITDA per US selling location2 to $1.5 million during 2021. We closed 14 acquisitions during the year and increased our Retail digital platform sales2 to $2.1 billion.

 

 

Potash adjusted EBITDA surpassed $1 billion in the fourth quarter and increased 130 percent in the full year of 2021 to $2.7 billion. We achieved record sales volumes of 13.6 million tonnes in 2021 due to our capability to quickly ramp up production from our flexible, low-cost network of six mines. We progressed our Potash Next Generation initiatives and produced 1 million tonnes in 2021 using tele-remote and autonomous mining techniques.

 

 

Nitrogen adjusted EBITDA was $921 million in the fourth quarter of 2021 and increased 114 percent to $2.3 billion in the full year of 2021. We completed our phase 1 brownfield expansion projects on time and on budget, launched a second phase of projects and progressed decarbonization initiatives.

 

 

Phosphate adjusted EBITDA was $196 million in the fourth quarter of 2021 and increased 133 percent to $540 million in the full year of 2021.

1 This financial measure including related guidance, if applicable, is a non-IFRS financial measure. See the “Non-IFRS Financial Measures” section for further information.

2 This is a supplementary financial measure. See the “Other Financial Measures” section for further information.

3 Net earnings from continuing operations.

 

1


Market Outlook

Agriculture and Retail

 

 

Global inventory for key grains and oilseeds remains historically low due to a combination of weather-related events and strong demand fueled by a greater focus on global food security and recovering feed and bio-energy related markets.

 

 

Corn and soybean prices in the US and Brazil remain very strong and prospective crop margins are well above the 10-year average. We expect this will incentivize growers to invest in their crops.

 

 

US growers experienced favorable fall weather conditions that combined with strong crop economics, supported a second consecutive year of strong fall fertilizer application. We expect overall planted area of major crops to be similar to 2021 levels, with corn and soybean acreage in the range of 91 to 93 million and 87 to 89 million, respectively.

 

 

Growers in Brazil planted an additional 4 million acres of soybeans which was a second consecutive year of record planting. However, yields have been impacted by drought conditions in major growing regions. We expect strong crop economics will support total Brazilian planted acreage and crop input demand in 2022. Australian growers continue to experience favorable weather conditions and harvested record wheat production.

 

 

Nutrien is well-positioned on fertilizer and crop protection product inventory to begin the North American planting season. Our Retail adjusted EBITDA guidance assumes there was some pull forward of fertilizer sales volumes due to the strong fall season in North America and that Retail fertilizer margins return to historical average levels after increasing in 2021 due to strategic procurement in a rising price environment.

Crop Nutrient Markets

 

 

Global potash prices increased in response to record global demand of 70 million in 2021 and tightness of supply due to competitor mine flooding, new project delays and uncertainty around sanctions imposed on Belarus by the US and Europe. We believe that many of these supply issues will continue into 2022, including additional restrictions imposed on Belarus potash transported through Lithuania. We estimate 2022 global shipments in a range of 68 to 71 million tonnes.

 

 

Nutrien expects record potash sales volumes between 13.7 to 14.3 million tonnes in 2022. This forecast assumes sanctions on Belarus have a temporary impact on global supply. If there was a more significant long-term impact on global supply, Nutrien has the capability to further ramp up production by hiring additional employees and incurring some small incremental capital expenditures.

 

 

Nitrogen prices have been supported by strong demand, soaring energy prices in Europe, and government restrictions and geopolitical risks in key export markets. Global urea prices softened in early 2022 during a seasonally slow period, however, ammonia and nitrates prices continue to strengthen due to supply side constraints. North American natural gas prices increased in early 2022 but we expect Henry Hub prices to average between $3.75 and $4.25 per MMBtu in 2022, well below import pricing levels in Europe and Asia.

 

 

We expect to increase Nitrogen sales volumes to 10.8 to 11.3 million tonnes in 2022 with the completion of Phase 1 brownfield expansion projects in 2021 and higher anticipated operating rates.

 

 

Phosphate prices have been supported by the expected reduction in supply from China due to export restrictions and elevated raw material input cost. This is compounded by tight inventories in key import markets such as India.

 

2


Financial Outlook and Guidance

Based on market factors detailed above, we are issuing full-year 2022 adjusted EBITDA guidance of $10.0 to $11.2 billion and full-year 2022 adjusted net earnings guidance of $10.20 to $11.80 per share. Adjusted net earnings per share guidance includes our plans to allocate a minimum of $2 billion to share repurchases in 2022 on a balanced cadence throughout the year.

All guidance numbers, including those noted above and related sensitives are outlined in the tales below.

 

2022 Guidance Ranges 1    Low                High     

  Adjusted net earnings per share 2

   $ 10.20                         $ 11.80  

  Adjusted EBITDA (billions) 2

   $ 10.0        $ 11.2  

  Retail Adjusted EBITDA (billions)

   $ 1.7        $ 1.8  

  Potash Adjusted EBITDA (billions)

   $ 5.0        $ 5.5  

  Nitrogen Adjusted EBITDA (billions)

   $ 3.2        $ 3.6  

  Phosphate Adjusted EBITDA (millions)

   $ 500        $ 600  

  Potash sales tonnes (millions) 3

     13.7          14.3  

  Nitrogen sales tonnes (millions) 3

     10.8          11.3  

  Depreciation and amortization (billions)

   $ 2.0        $ 2.1  

  Effective tax rate on adjusted earnings

     25        26

  Sustaining capital expenditures (billions) 4

   $ 1.2              $ 1.3  
     Impact to  
2022 Annual Assumptions & Sensitivities 1    Adjusted
EBITDA
            Adjusted
EPS 5
 

  $1/MMBtu change in NYMEX 6

   $          180        $         0.25  

  $25/tonne change in realized potash selling prices

   $ 290        $ 0.40  

  $25/tonne change in realized ammonia selling prices

   $ 50        $ 0.07  

  $25/tonne change in realized urea selling prices

   $ 80        $ 0.11  

  2022 FX Rate CAD to USD

       1.26     

  2022 NYMEX natural gas ($US/MMBtu)

           ~$ 4.00           

  1  See the “Forward-Looking Statements” section.

  2  This is a non-IFRS financial measure. See the “Non-IFRS Financial Measures” section.

  3  Manufactured products only. Nitrogen excludes ESN® products.

  4  This is a supplementary financial measure. See the Refer to “Other Financial Measures” section for further information.

  5  Assumes 546 million shares outstanding.

  6  Nitrogen related impact.

Consolidated Results

 

    Three Months Ended December 31     Twelve Months Ended December 31  

(millions of US dollars)

    2021       2020       % Change       2021       2020       % Change  

Sales

    7,267       4,052       79       27,712       20,908       33  

Freight, transportation and distribution

    198       202       (2     851       855       -  

Cost of goods sold

    3,863       2,685       44       17,452       14,814       18  

Gross margin

    3,206       1,165       175       9,409       5,239       80  

Expenses

    1,379       762       81       4,628       4,337       7  

Net earnings

    1,207       316       282       3,179       459       593  

Adjusted EBITDA 1

    2,463       768       221       7,126       3,667       94  

Diluted net earnings per share

    2.11       0.55       284       5.52       0.81       581  

Adjusted net earnings per share 1

    2.47       0.24       929       6.23       1.80       246  

Cash provided by operating activities

    3,637       2,778       31       3,886       3,323       17  

Free cash flow 1

    1,549       196       690       4,300       1,830       135  

Free cash flow including changes in non-cash

    operating working capital 1

    3,183       2,370       34       2,639       2,404       10  

  1  These are non-IFRS financial measures. See the “Non-IFRS Financial Measures” section.

Net earnings and adjusted EBITDA increased significantly in the fourth quarter and full year of 2021 compared to the same periods in 2020. This was due to higher net realized selling prices across our nutrient businesses, higher potash sales volumes, strong organic and proprietary product sales growth in Retail. In 2020, we recorded a non-cash impairment of $824 million primarily related to our Phosphate business and a gain of $250 million realized in the fourth quarter of 2020 related to the Misr Fertilizers Production Company

 

3


S.A.E. (“MOPCO”) divestment with no similar transactions in 2021. Cash flow provided by operating activities increased in the fourth quarter and full year of 2021 compared to the same periods in 2020 due primarily to higher net earnings. The COVID-19 pandemic had a limited impact on our results during the fourth quarter and full year of 2021.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2021 to the results for the three and twelve months ended December 31, 2020, unless otherwise noted.

 

 Nutrien Ag Solutions (“Retail”)

 

    Three Months Ended December 31  
  (millions of US dollars, except   Dollars           Gross Margin           Gross Margin (%)  
        as otherwise noted)   2021     2020     % Change           2021     2020     % Change           2021     2020  

Sales

                   

  Crop nutrients

    2,035       1,108       84         428       236       81         21       21  

  Crop protection products

    1,113       828       34         414       343       21         37       41  

  Seed

    189       152       24         57       58       (2       30       38  

  Merchandise

    270       240       13         45       41       10         17       17  

  Nutrien Financial

    51       37       38         51       37       38         100       100  

  Services and other

    267       290       (8       225       207       9         84       71  

  Nutrien Financial elimination 1

    (47     (37     27         (47     (37     27         100       100  
    3,878       2,618       48         1,173       885       33         30       34  

Cost of goods sold

    2,705       1,733       56                

Gross margin

    1,173       885       33                

Expenses 2

    911       768       19                

Earnings before finance
costs and taxes (“EBIT”)

    262       117       124                

Depreciation and amortization

    178       180       (1              

EBITDA

    440       297       48                

Adjustments 3

    2       -       n/m                

Adjusted EBITDA

    442       297       49                                                          

  1  Represents elimination for the interest and service fees charged by Nutrien Financial to Retail branches.

  2  Includes selling expenses of $848 million (2020 – $727 million).

  3  See Note 2 to the unaudited condensed consolidated financial statements.

 

 

 

 

    Twelve Months Ended December 31  
  (millions of US dollars, except   Dollars           Gross Margin           Gross Margin (%)  
       as otherwise noted)   2021     2020     % Change           2021     2020     % Change           2021     2020  

Sales

                   

  Crop nutrients

    7,290       5,200       40         1,597       1,130       41         22       22  

  Crop protection products

    6,333       5,602       13         1,551       1,303       19         24       23  

  Seed

    2,008       1,790       12         419       363       15         21       20  

  Merchandise

    1,033       943       10         172       157       10         17       17  

  Nutrien Financial

    189       129       47         189       129       47         100       100  

  Services and other

    1,051       1,241       (15       842       774       9         80       62  

  Nutrien Financial elimination

    (170     (120     42         (170     (120     42         100       100  
    17,734       14,785       20         4,600       3,736       23         26       25  

Cost of goods sold

    13,134       11,049       19                

Gross margin

    4,600       3,736       23                

Expenses 1

    3,378       2,974       14                

EBIT

    1,222       762       60                

Depreciation and amortization

    706       668       6                

EBITDA

    1,928       1,430       35                

Adjustments 2

    11       -       n/m                

Adjusted EBITDA

    1,939       1,430       36                                                          

  1  Includes selling expenses of $3,124 million (2020 – $2,795 million).

  2  See Note 2 to the unaudited condensed consolidated financial statements.

 

4


 

Adjusted EBITDA increased in the fourth quarter and full year of 2021 due to increased sales and gross margin achieved through market share growth, strong agriculture fundamentals and expansion in South America. Gross margin increases were supported by strategic procurement of crop nutrients and crop protection products in a rising price environment and a 22 percent increase in proprietary product related gross margin. Retail cash operating coverage ratio1 declined to 58 percent in 2021 due to significantly higher gross margin.

 

 

Crop nutrients sales increased in the fourth quarter and full year of 2021 due to record sales volumes and higher selling prices. Gross margin per tonne increased by $31 per tonne in 2021 due to strategic purchasing in a rising price environment and higher proprietary product sales.

 

 

Crop protection products sales increased in the fourth quarter and full year of 2021 due to market share growth, higher prices and increased proprietary product sales across all geographies, especially in Australia where uptake by customers was exceptional. The reliability of our supply chain, growth in proprietary product contribution and strategic procurement supports our ability to deliver on strong grower demand throughout the year.

 

 

Seed sales increased in the fourth quarter primarily due to significant organic growth achieved in South America and Australia following recent expansion initiatives and acquisitions. Gross margin percentage decreased in the fourth quarter due to the timing and mix of seed sales in the US. Seed sales for the full year of 2021 increased in all key regions where we operate due to higher planted acreage, higher prices and significant organic growth in South America. Gross margin percentage for 2021 increased due to price increases, including from our proprietary product.

 

 

Merchandise sales increased in the fourth quarter and full year of 2021 primarily driven by strong grower and rancher purchasing in Australia.

 

 

Nutrien Financial sales increased in the fourth quarter and full year of 2021 due to higher utilization and adoption of our programs. At the end of the fourth quarter of 2021 net receivables in the programs were $2.2 billion, an increase of $0.8 billion compared to the same period in 2020, while credit loss was minimal in 2021 and 2020 due to strong credit evaluation and collection as well as favorable market conditions this past year.

 

 

Services and other sales decreased in the fourth quarter and full year of 2021 compared to the same periods in 2020 due to the divestiture of an Australian livestock export business in the fourth quarter of 2020, which more than offset increases in other Australian services and higher US custom application sales. Despite the change in revenue mix, gross margin increased and the impact to gross margin percentage was favorable for both the fourth quarter and full year of 2021.

 

 Potash

 

    Three Months Ended December 31  
  (millions of US dollars, except   Dollars           Tonnes (thousands)           Average per Tonne  
     as otherwise noted)         2021           2020      % Change                 2021         2020      % Change                 2021           2020      % Change  

Manufactured product

                        

Net sales

                        

North America

    497       199        150       1,002     1,041        (4       494       192        157  

Offshore

    923       251        268       2,054     1,613        27         450       156        188  
    1,420       450        216       3,056     2,654        15         465       170        174  

Cost of goods sold

    305       305        -                  100       116        (14

Gross margin – total

    1,115       145        669             365       54        576  

Expenses 1

    179       49        265       Depreciation and amortization

 

            38       46        (17

EBIT

    936       96        875       Gross margin excluding depreciation

 

        

Depreciation and amortization

    117       123        (5    

and amortization – manufactured 3

 

            403       100        302  

EBITDA

    1,053       219        381       Potash cash cost of product

 

        

Adjustments 2

    -       1        (100    

manufactured 3

 

            70       71        (1

Adjusted EBITDA

    1,053       220        379                                                 

  1  Includes provincial mining taxes of $173 million (2020 – $40 million).

  2  See Note 2 to the unaudited condensed consolidated financial statements.

  3  These are non-IFRS financial measures. See the “Non-IFRS Financial Measures” section.

 

 

1 This financial measure is a non-IFRS financial measure. See the “Non-IFRS Financial Measures” section for further information.

 

5


    Twelve Months Ended December 31  
  (millions of US dollars, except   Dollars           Tonnes (thousands)           Average per Tonne  
     as otherwise noted)         2021           2020      % Change                 2021         2020      % Change                 2021           2020      % Change  

Manufactured product

                        

Net sales

                        

North America

    1,638       908        80       5,159     4,815        7         317       189        68  

Offshore

    2,398       1,238        94       8,466     8,009        6         283       155        83  
    4,036       2,146        88       13,625     12,824        6         296       167        77  

Cost of goods sold

    1,285       1,183        9                  94       92        2  

Gross margin – total

    2,751       963        186             202       75        169  

Expenses 1

    512       248        106       Depreciation and amortization

 

            36       35        2  

EBIT

    2,239       715        213       Gross margin excluding depreciation

 

        

Depreciation and amortization

    488       452        8      

and amortization – manufactured

 

            238       110        116  

EBITDA

    2,727       1,167        134       Potash cash cost of product

 

        

Adjustments 2

    9       23        (61    

manufactured

 

            63       59        7  

Adjusted EBITDA

    2,736       1,190        130                                                 

  1  Includes provincial mining taxes of $466 million (2020 – $201 million).

  2  See Note 2 to the unaudited condensed consolidated financial statements.

 

 

Adjusted EBITDA increased in the fourth quarter and full year of 2021 due to higher net realized selling prices and record sales volumes attributed to our ability to increase production by nearly 1 million tonnes.

 

 

Sales volumes were a record for the fourth quarter as we surged production to meet strong global demand and very tight global supply. We achieved this despite weather-related issues that temporarily impacted rail deliveries. North America and Offshore sales volumes in the full year of 2021 were the highest on record underpinned by the reliable supply from our flexible, low-cost network of six mines and integrated transportation and logistics system.

 

 

Net realized selling price increased in the fourth quarter and full year of 2021 due to strong global demand supported by higher crop prices, impacts to global supply caused by competitor outages and project delays as well as uncertainty regarding future sanctions on Belarus.

 

 

Cost of goods sold per tonne decreased in the fourth quarter due to lower depreciation and amortization compared to the same period of 2020 that was caused by production mix and timing of maintenance projects. Cost of goods sold per tonne increased for the full year of 2021 primarily due to higher royalties resulting from increased selling prices, a stronger Canadian dollar and cost inflation for energy and other inputs.

Canpotex Sales by Market

 

(percentage of sales volumes, except as

    Three Months Ended December 31             Twelve Months Ended December 31        
    otherwise noted)             2021               2020             Change               2021               2020             Change  

Latin America

    37       31       6       38       32       6  

Other Asian markets 1

    34       24       10       35       25       10  

China

    12       21       (9     11       22       (11

Other markets

    11       7       4       10       7       3  

India

    6       17       (11     6       14       (8
      100       100               100       100          

  1  All Asian markets except China and India.

 

6


 Nitrogen

 

 

 

 

  Three Months Ended December 31  
(millions of US dollars, except   Dollars    

 

 

 

    Tonnes (thousands)    

 

 

 

    Average per Tonne   
    as otherwise noted)         2021           2020       % Change                 2021         2020            % Change                 2021           2020            % Change  

Manufactured product

 

                     

Net sales

                                  

Ammonia

    519       157       231       790     730        8         656       216        204  

Urea

    552       230       140       824     853        (3             670       270        148  

Solutions, nitrates and

    sulfates

    385       168       129    

 

 

 

  1,221     1,262        (3  

 

 

 

    316       133        138  
    1,456       555       162       2,835     2,845        -         514       195        164  

Cost of goods sold

    725       460       58    

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

    256       162        58  

Gross margin – manufactured

    731       95       669                  258       33        682  

Gross margin – other 1

    23       17       35    

 

 

 

   Depreciation and amortization

 

   

 

 

 

 

 

    52       51        2  

Gross margin – total

    754       112       573      

 Gross margin excluding depreciation

 

      

Income

    (2     (254     (99  

 

 

 

 

  and amortization – manufactured 3

 

    310       84        268  

EBIT

    756       366       107      

 Ammonia controllable cash cost of

 

      

Depreciation and amortization

    148       146       1    

 

 

 

 

  product manufactured 3

 

    45       40        13  

EBITDA

    904       512       77                    

Adjustments 2

    17       (246     n/m    

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

Adjusted EBITDA

    921       266       246      

 

 

 

 

 

   

 

   

 

 

 

 

 

    

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

1 Includes other nitrogen (including ESN® and Rainbow) and purchased products and comprises net sales of $193 million (2020 – $114 million) less cost of goods sold of $170 million (2020 – $97 million).

2 See Note 2 to unaudited condensed consolidated financial statements.

3 These are non-IFRS financial measures. See the “Non-IFRS Financial Measures” section.

 

 

 

 

 

 

  Twelve Months Ended December 31  
(millions of US dollars, except   Dollars    

 

 

 

    Tonnes (thousands)    

 

 

 

    Average per Tonne   
    as otherwise noted)   2021     2020     % Change           2021   2020      % Change           2021     2020      % Change  

Manufactured product

 

                     

Net sales

                       

Ammonia

    1,393       621       124       2,919     2,778        5         477       224        113  

Urea

    1,463       933       57       3,059     3,475        (12       478       268        78  

Solutions, nitrates and

    sulfates

    1,128       668       69    

 

 

 

  4,747     4,713        1    

 

 

 

    238       142        68  
        3,984           2,222       79       10,725     10,966        (2       371       203        83  

Cost of goods sold

    2,353       1,804       30    

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

    219       165        33  

Gross margin – manufactured

    1,631       418       290                  152       38        300  

Gross margin – other 1

    95       57       67    

 

 

 

   Depreciation and amortization

 

   

 

 

 

 

 

    52       55        (5

Gross margin – total

    1,726       475       263      

 Gross margin excluding depreciation

 

      

Income

    (3     (225     (99  

 

 

 

 

  and amortization – manufactured

 

    204       93        120  

EBIT

    1,729       700       147      

 Ammonia controllable cash cost of

      

Depreciation and amortization

    557       599       (7  

 

 

 

 

  product manufactured

 

    50       43        16  

EBITDA

    2,286       1,299       76                    

Adjustments 2

    22       (219     n/m    

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

Adjusted EBITDA

    2,308       1,080       114      

 

 

 

 

 

   

 

   

 

 

 

 

 

    

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

1 Includes other nitrogen (including ESN® and Rainbow) and purchased products and comprises net sales of $705 million (2020 – $518 million) less cost of goods sold of $610 million (2020 – $461 million).

2 See Note 2 to unaudited condensed consolidated financial statements.

 

 

Adjusted EBITDA increased in the fourth quarter and full year of 2021 primarily due to higher net realized selling prices, which more than offset higher natural gas costs.

 

 

Sales volumes decreased slightly in the fourth quarter and full year of 2021 due to more planned plant turnaround activity, temporary production outages and lower inventory volumes at the beginning of 2021 compared to the same period in 2020. Ammonia operating rates reached 97 percent in the fourth quarter and 90 percent for the full year of 2021.

 

 

Net realized selling price in the fourth quarter and full year of 2021 was higher due to higher benchmark prices resulting from the strength in global demand and tight global supply caused by production outages and higher energy prices in key nitrogen exporting regions.

 

 

Cost of goods sold per tonne increased during the fourth quarter and full year of 2021 primarily due to higher natural gas costs.

 

7


Natural Gas Prices in Cost of Production

 

         Three Months Ended December 31              Twelve Months Ended December 31      
(US dollars per MMBtu, except as otherwise noted)              2021               2020        % Change                2021                2020        % Change  

Overall gas cost excluding realized derivative impact

     6.43       2.71        137        4.60        2.31        99  

Realized derivative impact

     (0.03     0.03        n/m        0.01        0.05        (80

Overall gas cost

     6.40       2.74        134        4.61        2.36        95  

Average NYMEX

     5.83       2.66        119        3.84        2.08        85  

Average AECO

     3.93       2.10        87        2.84        1.68        69  

 

 

Natural gas prices in our cost of production increased in the fourth quarter and full year of 2021 as a result of higher North American gas index prices and increased gas costs in Trinidad, where our gas prices are linked to ammonia benchmark prices.

 

 Phosphate

 

 

 

 

  Three Months Ended December 31  
(millions of US dollars, except   Dollars    

 

 

 

    Tonnes (thousands)    

 

 

 

    Average per Tonne   
       as otherwise noted)   2021     2020     % Change           2021     2020      % Change           2021     2020      % Change  

Manufactured product

 

                     

Net sales

                       

Fertilizer

          377             180       109         509       466        9         741       387        91  

Industrial and feed

    155       100       55    

 

 

 

    202       182        11    

 

 

 

    766       551        39  
    532       280       90         711       648        10         749       433        73  

Cost of goods sold

    374       265       41    

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

    526       410        28  

Gross margin – manufactured

    158       15       953                  223       23        870  

Gross margin – other 1

    5       1       400    

 

 

 

     Depreciation and amortization      

 

 

 

 

 

    55       60        (9

Gross margin – total

    163       16       919        

 Gross margin excluding depreciation

        

Expenses

    10       (8     n/m    

 

 

 

   

  and amortization – manufactured 3

      278       83        234  

EBIT

    153       24       538                    

Depreciation and amortization

    39       39       -    

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

EBITDA

    192       63       205    

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

Adjustments 2

    4       -       n/m    

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

Adjusted EBITDA

    196       63       211      

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

1 Includes other phosphate and purchased products and comprises net sales of $61 million (2020 – $40 million) less cost of goods sold of $56 million (2020 – $39 million).

2 See Note 2 to the unaudited condensed consolidated financial statements.

3 This is a non-IFRS financial measure. See the “Non-IFRS Financial Measures” section.

 

 

 

 

 

 

  Twelve Months Ended December 31  
(millions of US dollars, except   Dollars    

 

 

 

    Tonnes (thousands)    

 

 

 

    Average per Tonne   
       as otherwise noted)   2021     2020     % Change           2021     2020      % Change           2021     2020      % Change  

Manufactured product

 

                     

Net sales

                       

Fertilizer

    1,108       671       65         1,840       2,048        (10       602       328        84  

Industrial and feed

          520             404       29    

 

 

 

    779       733        6    

 

 

 

    667       552        21  
    1,628       1,075       51         2,619       2,781        (6       622       387        61  

Cost of goods sold

    1,227       1,044       18    

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

    469       376        25  

Gross margin – manufactured

    401       31       n/m                  153       11        n/m  

Gross margin – other 1

    20       5       300    

 

 

 

     Depreciation and amortization      

 

 

 

 

 

    58       78        (26

Gross margin – total

    421       36       n/m        

 Gross margin excluding depreciation

        

Expenses

    36       791       (95  

 

 

 

   

  and amortization – manufactured

      211       89        136  

EBIT

    385       (755     n/m                    

Depreciation and amortization

    151       218       (31  

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

EBITDA

    536       (537     n/m                    

Adjustments 2

    4       769       (99  

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

Adjusted EBITDA

    540       232       133      

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

    

 

 

 

 

 

1 Includes other phosphate and purchased products and comprises net sales of $201 million (2020 – $127 million) less cost of goods sold of $181 million (2020 – $122 million).

2 See Note 2 to the unaudited condensed consolidated financial statements.

 

 

 

8


 

Adjusted EBITDA increased in the fourth quarter and full year of 2021 due to higher net realized selling prices, which more than offset higher raw material costs and lower sales volumes for the full year.

 

 

Sales volumes increased in the fourth quarter of 2021 due to the timing and sales mix of certain fertilizer products and higher operating rates. Lower inventory levels at the beginning of 2021 and a greater mix of higher P2O5 content sales resulted in slightly lower sales volumes during the full year of 2021. P2O5 production increased in the fourth quarter and full year of 2021 due to improved reliability at our Aurora and White Springs plants.

 

 

Net realized selling price increased in the fourth quarter and full year of 2021 as a result of robust global phosphate demand, tight inventories and higher global raw material costs. Industrial and feed prices increased to a lesser extent than fertilizer in both comparative periods due to a lag in price realizations relative to spot prices.

 

 

Cost of goods sold per tonne increased in the fourth quarter and full year of 2021 primarily due to significantly higher raw material input costs which more than offset lower depreciation and amortization. Comparative results for the full year of 2020 were also impacted by a $46 million favorable change in estimate related to an asset retirement obligation recorded in the second quarter of 2020.

 

 Corporate and Others

 

(millions of US dollars, except    Three Months Ended December 31      Twelve Months Ended December 31  

       as otherwise noted)

               2021                 2020         % Change                  2021                  2020              % Change  

Sales 1

     -       12       (100      -        82        (100

Cost of goods sold

     -       11       (100      -        74        (100

Gross margin

     -       1       (100      -        8        (100

Selling expenses

     3       (7     n/m        (21      (24      (13

General and administrative expenses

     93       78       19        275        269        2  

Share-based compensation expense

     73       60       22        198        69        187  

Impairment of assets

     -       -       -        -        5        (100

Other expenses

     112       76       47        253        230        10  

EBIT

     (281     (206     36        (705      (541      30  

Depreciation and amortization

     15       11       36        49        52        (6

EBITDA

     (266     (195     36        (656      (489      34  

Adjustments 2

     116       111       5        348        203        71  

Adjusted EBITDA

     (150     (84     79        (308      (286      8  

1 Primarily relates to our non-core Canadian business that was sold in 2020.

 

2 See Note 2 to the unaudited condensed consolidated financial statements.

 

 

 

Share-based compensation expense was higher in the fourth quarter and full year of 2021 compared to the same periods in 2020 due to an increase in our share price resulting in a higher value of share-based awards outstanding.

 

 

Other expenses were higher in the fourth quarter and full year of 2021 compared to the same periods in 2020 due to higher foreign exchange losses, higher expense related to asset retirement obligations and accrued environment costs for our non-operating sites from changes in our cost and discount rate estimates, and additional cloud computing related expenses recognized in the first half of 2021 due to our change in accounting policy. This was partially offset by lower integration and restructuring related costs.

 

 Eliminations

Eliminations of gross margin between operating segments for the full year of 2021 were $(89) million compared to a $21 million gross margin recovery for the same period in 2020. We had significant eliminations in 2021 due to higher-margin inventories held by our Retail segment as global commodity benchmark prices increased. Eliminations are not part of the Corporate and Others segment.

 

9


Finance Costs, Income Tax Expense (Recovery) and

Other Comprehensive Income

 

(millions of US dollars, except    Three Months Ended December 31      Twelve Months Ended December 31  

       as otherwise noted)

               2021                  2020         % Change                  2021                  2020          % Change  

Finance costs

     246        119       107        613        520        18  

Income tax expense (recovery)

     374        (32     n/m        989        (77      n/m  

Other comprehensive income

     72        280       (74      78        194        (60

 

 

Finance costs in the fourth quarter and full year of 2021 were higher compared to the same periods in 2020 mainly due to a loss of $142 million on early extinguishment of long-term debt, which primarily represents interest that we would have paid in future years if the long-term debt was not extinguished.

 

 

Income tax expense in the fourth quarter and full year of 2021 was higher as a result of significantly higher earnings in 2021 compared to the same periods in 2020. In addition, in 2020, discrete tax recoveries of $80 million primarily related to recoveries of prior year taxes due to US legislative changes.

 

 

Other comprehensive income is primarily driven by changes in the currency translation of our foreign operations and share price movement of our investment in Sinofert Holdings Ltd. In 2020, we had a higher gain on translation of our Retail operations in Australia as the Australian dollar strengthened relative to the US dollar. In 2021, the Australian dollar weakened relative to the US dollar resulting in lower other comprehensive income.

 

10


Forward-Looking Statements

Certain statements and other information included in this document, including within the “Financial Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien’s business strategies, plans, prospects and opportunities; Nutrien’s 2022 full-year guidance, including expectations regarding our adjusted net earnings per share and adjusted EBITDA (consolidated and by segment); expectations regarding our growth and capital allocation intentions and strategies; capital spending expectations for 2022; expectations regarding performance of our operating segments in 2022, including our operating segment market outlooks and market conditions for 2022, and the anticipated supply and demand for our products and services, expected market and industry conditions with respect to crop nutrient application rates, planted acres, grower crop investment, crop mix, prices and the impact of import and export volumes and economic sanctions; Nutrien’s ability to develop innovative and sustainable solutions; the negotiation of sales contracts; expected benefits from our brownfield expansion projects; and acquisitions and divestitures. These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty. The additional key assumptions that have been made include, among other things, assumptions with respect to our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, margins, demand, supply, product availability, supplier agreements, availability and cost of labor and interest, exchange and effective tax rates; assumptions with respect to global economic conditions and the accuracy of our market outlook expectations for 2022 and in the future; our expectations regarding the impacts, direct and indirect, of the COVID-19 pandemic on our business, customers, business partners, employees, supply chain, other stakeholders and the overall economy; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; our ability to maintain investment grade ratings and achieve our performance targets; our ability to successfully negotiate sales contracts; and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including tariffs, trade restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; political risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism; the occurrence of a major environmental or safety incident; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; the COVID-19 pandemic, including variants of the COVID-19 virus and the efficiency and distribution of vaccines, and its resulting effects on economic conditions, restrictions imposed by public health authorities or governments, including government-imposed vaccine mandates, fiscal and monetary responses by governments and financial institutions and disruptions to global supply chains; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the Securities Exchange Commission in the United States.

The purpose of our adjusted net earnings per share, adjusted EBITDA (consolidated and by segment) and sustaining capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

 

11


Terms & Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms and Definitions” section of our 2020 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

About Nutrien

Nutrien is the world’s largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. We produce and distribute approximately 27 million tonnes of potash, nitrogen and phosphate products world-wide. With this capability and our leading agriculture retail network, we are well positioned to supply the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic, environmental and social priorities. The scale and diversity of our integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders.

For Further Information:

Investor Relations:

Jeff Holzman

Vice President, Investor Relations

(306) 933-8545

Investors@nutrien.com

Media Relations:

Megan Fielding

Vice President, Brand & Culture Communications

(403) 797-3015

Contact us at: www.nutrien.com

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool

Such data is not incorporated by reference herein.

 

 

Nutrien will host a Conference Call on Thursday, February 17, 2022 at 10:00 am Eastern Time.

 

 

In order to expedite access to our conference call, each participant will be required to pre-register for the event:

   

Online: http://www.directeventreg.com/registration/event/3664097.

   

Via Phone: 1-888-869-1189 Conference ID 3664097.

 

Once the registration is complete, a confirmation will be sent providing the dial in number and both the Direct Event Passcode and your unique Registrant ID to join this call. For security reasons, please do not share your information with anyone else.

 

Live Audio Webcast: Visit http://www.nutrien.com/investors/events/2021-q4-earnings-conference-call

 

12


Appendix A - Selected Additional Financial Data

 

Selected Retail measures   Three Months Ended December 31             Twelve Months Ended December 31  

 

  2021     2020     2021     2020  

Proprietary products margin as a percentage of
product line margin (%)

       

Crop nutrients

    12       14       21       25  

Crop protection products

    14       11       34       32  

Seed

    39       37       44       46  

All products

    11       11       23       23  

Crop nutrients sales volumes (tonnes – thousands)

       

North America

    2,119       2,063       9,848       9,746  

International

    702       622       3,535       2,986  

Total

    2,821       2,685       13,383       12,732  

Crop nutrients selling price per tonne

       

North America

    725       413       556       421  

International

    708       413       512       367  

Total

    721       413       545       408  

Crop nutrients gross margin per tonne

       

North America

    154       89       133       99  

International

    144       85       82       55  

Total

    152       88       119       89  
Financial performance measures                 2021     2020  

Retail adjusted EBITDA margin (%) 1, 2

 

    11       10  

Retail adjusted EBITDA per US selling location (thousands of US dollars) 1, 2, 3

 

    1,481       1,075  

Retail adjusted average working capital to sales (%) 1, 3

 

    13       15  

Retail adjusted average working capital to sales excluding Nutrien Financial (%) 1, 4

 

    -       5  

Nutrien Financial adjusted net interest margin (%) 1, 4

 

    6.6       5.3  

Retail cash operating coverage ratio (%) 1, 4

 

    58       62  

Retail normalized comparable store sales (%) 4

 

            7       6  
  1   Rolling four quarters ended December 31, 2021 and 2020.

 

  2   These are supplementary financial measures. See the “Other Financial Measures” section.

 

  3   Excluding acquisitions.

 

  4   These are non-IFRS financial measures. See the “Non-IFRS Financial Measures” section.

 

 

Nutrien Financial    As at December 31, 2021  
 (millions of US dollars)    Current     

<31 days

past due

    

31–90 days

past due

    

>90 days

past due

     Gross
Receivables
     Allowance 1      Net
Receivables
 

 North America

     1,410        45        12        47        1,514        (26      1,488  

 International

     537        47        26        54        664        (2      662  

 Nutrien Financial receivables

     1,947        92        38        101        2,178        (28      2,150  
  1   Bad debt expense on the above receivables for the twelve months ended December 31, 2021 was $10 million (2020 – $26 million) in the Retail segment.

 

  2   Gross receivables include $1,792 million (2020 – $1,147 million) very low risk of default and $386 million (2020 – $270 million) of low risk of default.

 

 

 

13


Selected Nitrogen measures   Three Months Ended December 31     Twelve Months Ended December 31  
      2021       2020       2021       2020  

Sales volumes (tonnes – thousands)

       

Fertilizer

    1,578       1,740       6,028       6,750  

Industrial and feed

    1,257       1,105       4,697       4,216  

Net sales (millions of US dollars)

       

Fertilizer

    861       359       2,364       1,467  

Industrial and feed

    595       196       1,620       755  

Net selling price per tonne

       

Fertilizer

    545       206       392       217  

Industrial and feed

    473       178       345       179  
Production measures   Three Months Ended December 31     Twelve Months Ended December 31  
      2021       2020       2021       2020  

Potash production (Product tonnes – thousands)

    3,641       2,784       13,790       12,595  

Potash shutdown weeks 1

    -       -       14       38  

Ammonia production – total 2

    1,641       1,584       5,996       6,063  

Ammonia production – adjusted 2, 3

    1,069       1,035       3,932       4,102  

Ammonia operating rate (%) 3

    97       94       90       93  

P2O5 production (P2O5 tonnes – thousands)

    409       361       1,518       1,444  

P2O5 operating rate (%)

    95       84       89       85  

1   Represents weeks of full production shutdown, excluding the impact of any periods of reduced operating rates and planned routine annual maintenance shutdowns and announced workforce reductions.

 

2   All figures are provided on a gross production basis in thousands of product tonnes.

 

3   Excludes Trinidad and Joffre.

 

 

14


Appendix B - Non-IFRS Financial Measures

We use both International Financial Reporting Standards (“IFRS”) and certain non-IFRS financial measures to assess performance. Non-IFRS financial measures are financial measures disclosed by a company that (a) depict historical or expected future financial performance, financial position or cash flow of a company, (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the company, (c) are not disclosed in the financial statements of the company and (d) are not a ratio, fraction, percentage or similar representation. Non-IFRS ratios are financial measures disclosed by a company that are in the form of a ratio, fraction, percentage or similar representation that has a non-IFRS financial measure as one or more of its components, and that are not disclosed in the financial statements of the company.

These non-IFRS financial measures and non-IFRS ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-IFRS financial measures and non-IFRS ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-IFRS financial measures and non-IFRS ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-IFRS financial measures and non-IFRS ratios, their compositions, and why management uses each measure. It includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-IFRS financial measures and non-IFRS ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and certain foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses, gain or loss on disposal of certain businesses and investments, and IFRS adoption transition adjustments. In 2021, we amended our calculation of adjusted EBITDA to adjust for the impact of integration and restructuring related costs and cloud computing transition adjustment. There were no similar expenses in the comparative period.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

 

    Three Months Ended December 31     Twelve Months Ended December 31  

 (millions of US dollars)

    2021       2020       2021       2020  

 Net earnings

    1,207       316       3,179       459  

 Finance costs

    246       119       613       520  

 Income tax expense (recovery)

    374       (32     989       (77

 Depreciation and amortization

    497       499       1,951       1,989  

 EBITDA 1

    2,324       902       6,732       2,891  

 Share-based compensation expense

    73       60       198       69  

 Foreign exchange loss, net of related derivatives

    38       15       39       19  

 Integration and restructuring related (recovery) costs

    (4     22       43       60  

 Impairment of assets

    21       1       33       824  

 COVID-19 related expenses 2

    11       18       45       48  

 Loss on disposal of business

    -       -       -       6  

 Net gain on disposal of investment in MOPCO

    -       (250     -       (250

 Cloud computing transition adjustment 3

    -       -       36       -  

 Adjusted EBITDA

    2,463       768       7,126       3,667  

1 EBITDA is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

2 COVID-19 related expenses primarily consist of increased cleaning and sanitization costs, the purchase of personal protective equipment, discretionary supplemental employee costs, and costs related to construction delays from access limitations and other government restrictions.

3 Cloud computing transition adjustment relates to cloud computing costs in prior years that no longer qualify for capitalization based on an agenda decision issued by the IFRS Interpretations Committee in April 2021.

 

15


Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and certain foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses (including those recorded under finance costs), gain or loss on disposal of certain businesses and investments, IFRS adoption transition adjustments and gain/loss on early extinguishment of debt. We generally apply the annual forecasted effective tax rate to our adjustments during the year and, at year-end, we apply the actual effective tax rate. If the effective tax rate is significantly different from our forecasted effective tax rate due to adjustments or discrete tax impacts, we apply a tax rate that excludes those items. For material adjustments, we apply a tax rate specific to the adjustment. In 2021, we amended our calculation of adjusted net earnings to adjust for the impact of integration and restructuring related costs, cloud computing transition adjustment, and gain/loss on early extinguishment of debt. There were no similar expenses in the comparative period.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 

    

Three Months Ended

December 31, 2021

   

Twelve Months Ended

December 31, 2021

 

(millions of US dollars, except as otherwise
noted)

    
Increases
(Decreases)
 
 
    Post-Tax      

Per
Diluted
Share
 
 
 
   
Increases
(Decreases)
 
 
     Post-Tax      

Per
Diluted
Share
 
 
 

Net earnings attributable to equity holders of

    Nutrien

       1,201       2.11          3,153       5.52  

Adjustments:

             

Share-based compensation expense

     73       56       0.10       198        151       0.27  

Foreign exchange loss, net of related derivatives

     38       29       0.05       39        30       0.05  

Integration and restructuring related (recovery)
costs

     (4     (3     (0.01     43        33       0.06  

Impairment of assets

     21       16       0.03       33        25       0.04  

COVID-19 related expenses

     11       8       0.01       45        34       0.06  

Cloud computing transition adjustment

     -       -       -       36        27       0.05  

Loss on early extinguishment of debt

     142       104       0.18       142        104       0.18  

Adjusted net earnings

             1,411       2.47                3,557       6.23  

 

    

Three Months Ended

December 31, 2020

   

Twelve Months Ended

December 31, 2020

 

(millions of US dollars, except as otherwise
noted)

    
Increases
(Decreases)
 
 
    Post-Tax      

Per
Diluted
Share
 
 
 
   
Increases
(Decreases)
 
 
    Post-Tax      

Per
Diluted
Share
 
 
 

Net earnings attributable to equity holders of

    Nutrien

       316       0.55         459       0.81  

Adjustments:

            

Share-based compensation expense

     60       36       0.06       69       50       0.09  

Foreign exchange loss, net of
related derivatives

     15       9       0.02       19       14       0.02  

Integration and restructuring related costs

     22       13       0.03       60       44       0.08  

Impairment of assets

     1       1       -       824       657       1.15  

COVID-19 related expenses

     22       13       0.02       67       49       0.09  

Loss on disposal of business

     -       -       -       6       4       -  

Net gain on disposal of investment in MOPCO

     (250     (250     (0.44     (250     (250     (0.44

Adjusted net earnings

             138       0.24               1,027       1.80  

 

16


Adjusted EBITDA (Consolidated) and Adjusted Net Earnings Per Share Guidance

Adjusted EBITDA and adjusted net earnings per share guidance are forward-looking non-IFRS financial measures. We do not provide a reconciliation of such forward-looking measures to the most directly comparable financial measures calculated and presented in accordance with IFRS due to unknown variables and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. Guidance for adjusted EBITDA and adjusted net earnings per share excludes the impacts of share-based compensation, certain foreign exchange gain/loss (net of related derivatives), integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses (including those recorded under finance costs), gain or loss on disposal of certain businesses and investments, IFRS adoption transition adjustments, and gain/loss on early extinguishment of debt.

Free Cash Flow and Free Cash Flow Including Changes in Non-Cash Operating Working Capital

Most directly comparable IFRS financial measure: Cash provided by (used in) operating activities.

Definition: Free cash flow is calculated as cash provided by (used in) operating activities less sustaining capital expenditures and before changes in non-cash operating working capital. Free cash flow including non-cash operating working capital is calculated as cash provided by operating activities less sustaining capital expenditures.

Why we use the measure and why it is useful to investors: For evaluation of liquidity and financial strength. These are also useful as indicators of our ability to service debt, meet other payment obligations and make strategic investments. These do not represent residual cash flow available for discretionary expenditures.

 

    Three Months Ended December 31     Twelve Months Ended December 31  

 (millions of US dollars)

    2021       2020       2021       2020  

 Cash provided by operating activities

    3,637       2,778       3,886       3,323  

 Sustaining capital expenditures

    (454     (408     (1,247     (919

 Free cash flow including changes in non-cash
operating working capital

    3,183       2,370       2,639       2,404  

 Changes in non-cash operating working capital

    1,634       2,174       (1,661     574  

 Free cash flow

    1,549       196       4,300       1,830  

Gross Margin Excluding Depreciation and Amortization Per Tonne - Manufactured

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne from manufactured products per tonne less depreciation and amortization per tonne. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS for the period excluding depreciation and amortization expense and inventory and other adjustments divided by the production tonnes for the period.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash cash COPM excludes the effects of production from other periods and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

 

17


    Three Months Ended December 31     Twelve Months Ended December 31  
 (millions of US dollars, except as otherwise noted)     2021       2020       2021       2020  
 Total COGS – Potash     305       305       1,285       1,183  
 Change in inventory     64       18       22       (10
 Other adjustments 1     1       (7     (6     (12
 COPM     370       316       1,301       1,161  
 Depreciation and amortization included in COPM     (115     (119     (430     (424
 Cash COPM     255       197       871       737  
 Production tonnes (tonnes – thousands)     3,641       2,784       13,790       12,595  

 Potash cash COPM per tonne

    70       71       63       59  

1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 

Ammonia Controllable Cash COPM Per Tonne

Most directly comparable IFRS financial measure: Total manufactured COGS for the Nitrogen segment.

Definition: The total of COGS for the Nitrogen segment excluding depreciation and amortization expense included in COGS, cash COGS for products other than ammonia, other adjustments, and natural gas and steam costs, divided by net ammonia production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Ammonia controllable cash COPM excludes the effects of production from other periods, the costs of natural gas and steam, and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

 

    Three Months Ended December 31     Twelve Months Ended December 31  

 (millions of US dollars, except as otherwise noted)

    2021       2020       2021       2020  

 Total Manufactured COGS – Nitrogen

    725       460       2,353       1,804  

 Total Other COGS – Nitrogen

    170       97       610       461  

 Total COGS – Nitrogen

    895       557       2,963       2,265  

 Depreciation and amortization in COGS

    (126     (127     (473     (522

 Cash COGS for products other than ammonia

    (519     (325     (1,740     (1,342

 Ammonia

       

Total cash COGS before other adjustments

    250       105       750       401  

Other adjustments 1

    (30     (6     (96     (52

Total cash COPM

    220       99       654       349  

Natural gas and steam costs

    (186     (71     (515     (235

Controllable cash COPM

    34       28       139       114  

 Production tonnes (net tonnes 2 – thousands)

    758       704       2,769       2,649  

 Ammonia controllable cash COPM per tonne

    45       40       50       43  

1  Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 

 2  Ammonia tonnes available for sale, as not upgraded to other Nitrogen products.

 

Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the working capital and sales of certain acquisitions (such as Ruralco Holdings Limited) during the first year following the acquisition. We also look at this metric excluding the sales and working capital of Nutrien Financial.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

 

18


    Rolling four quarters ended December 31, 2021  

 (millions of US dollars, except as otherwise noted)

            Q1 2021                   Q2 2021                   Q3 2021                   Q4 2021             Average/Total     

 Current assets

    9,160       9,300       8,945       9,924    

 Current liabilities

    (7,530     (7,952     (5,062     (7,828        

 Working capital

    1,630       1,348       3,883       2,096    

 Working capital from certain recent acquisitions

    -       -       -       -          

 Adjusted working capital

    1,630       1,348       3,883       2,096       2,239     

 Nutrien Financial working capital

    (1,221     (3,072     (2,820     (2,150        

 Adjusted working capital excluding Nutrien Financial

    409       (1,724     1,063       (54     (77)    

 Sales

    2,972       7,537       3,347       3,878    

 Sales from certain recent acquisitions

    -       -       -       -          

 Adjusted sales

    2,972       7,537       3,347       3,878       17,734     

 Nutrien Financial revenue

    (25     (59     (54     (51        

 Adjusted sales excluding Nutrien Financial

    2,947       7,478       3,293       3,827       17,545     

 Adjusted average working capital to sales (%)

            13     

 Adjusted average working capital to sales excluding Nutrien Financial (%)

 

      -     
    Rolling four quarters ended December 31, 2020  

 (millions of US dollars, except as otherwise noted)

            Q1 2020                   Q2 2020                   Q3 2020                   Q4 2020             Average/Total     

 Current assets

    8,423       8,230       7,324       8,013    

 Current liabilities

    (6,135     (6,200     (4,108     (6,856        

 Working capital

    2,288       2,030       3,216       1,157    

 Working capital from certain recent acquisitions

    (108     63       -       -          

 Adjusted working capital

    2,180       2,093       3,216       1,157       2,162     

 Nutrien Financial working capital

    (795     (2,108     (1,711     (1,392        

 Adjusted working capital excluding Nutrien Financial

    1,385       (15     1,505       (235     660     

 Sales

    2,661       6,764       2,742       2,618    

 Sales from certain recent acquisitions

    (348     (338     -       -          

 Adjusted sales

    2,313       6,426       2,742       2,618       14,099     

 Nutrien Financial revenue

    (16     (40     (36     (37        

 Adjusted sales excluding Nutrien Financial

    2,297       6,386       2,706       2,581       13,970     

 Adjusted average working capital to sales (%)

            15     

 Adjusted average working capital to sales excluding Nutrien Financial (%)

 

      5     

 

Nutrien Financial Adjusted Net Interest Margin

 

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial receivables outstanding for the last four rolling quarters.

 

Why we use the measure and why it is useful to investors: Used by credit rating agencies and other users to evaluate financial performance of Nutrien Financial.

 

 

 

 

19


    Rolling four quarters ended December 31, 2021  

 (millions of US dollars, except as otherwise noted)

            Q1 2021                   Q2 2021                   Q3 2021                   Q4 2021         Total/Average     

 Nutrien Financial revenue

    25       59       54       51    

 Deemed interest expense 1

    (6     (8     (10     (12        

 Net interest

    19       51       44       39       153     

 Average Nutrien Financial receivables

    1,221       3,072       2,820       2,150       2,316     

 Nutrien Financial adjusted net interest margin (%)

                                    6.6     

  1  Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

 

    Rolling four quarters ended December 31, 2020  
 (millions of US dollars, except as otherwise noted)   Q1 2020       Q2 2020         Q3 2020           Q4 2020     Total/Average     

 Nutrien Financial revenue

    16       40       36       37    

 Deemed interest expense 1

    (5     (15     (15     (14        

 Net interest

    11       25       21       23       80     

 Average Nutrien Financial receivables

    795       2,108       1,711       1,392       1,502     

 Nutrien Financial adjusted net interest margin (%)

                                    5.3     

 1   Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

 

Retail Cash Operating Coverage Ratio

 

Definition: Retail selling, general and administrative, and other expenses, excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

 

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate free cash flow.

 

 

 

 

    Rolling four quarters ended December 31, 2021  
 (millions of US dollars, except as otherwise noted)   Q1 2021     Q2 2021     Q3 2021     Q4 2021     Total     

 Selling expenses

    667       863       746       848       3,124     

 General and administrative expenses

    39       41       45       43       168     

 Other expenses

    15       34       17       20       86     

 Operating expenses

    721       938       808       911       3,378     

 Depreciation and amortization in operating expenses

    (175     (166     (180     (173     (694)    

 Operating expenses excluding depreciation and amortization

    546       772       628       738       2,684     

 Gross margin

    652       1,858       917       1,173       4,600     

 Depreciation and amortization in cost of goods sold

    2       3       2       5       12     

 Gross margin excluding depreciation and amortization

    654       1,861       919       1,178       4,612     

 Cash operating coverage ratio (%)

                                    58     
    Rolling four quarters ended December 31, 2020  
 (millions of US dollars, except as otherwise noted)   Q1 2020     Q2 2020     Q3 2020     Q4 2020     Total     

 Selling expenses

    635       764       669       727       2,795     

 General and administrative expenses

    38       30       34       33       135     

 Other expenses (income)

    16       32       (12     8       44     

 Operating expenses

    689       826       691       768       2,974     

 Depreciation and amortization in operating expenses

    (153     (161     (167     (177     (658)     

 Operating expenses excluding depreciation and amortization

    536       665       524       591       2,316     

 Gross margin

    541       1,627       683       885       3,736     

 Depreciation and amortization in cost of goods sold

    2       2       3       3       10     

 Gross margin excluding depreciation and amortization

    543       1,629       686       888       3,746     

 Cash operating coverage ratio (%)

                                    62     

 

20


Retail Normalized Comparable Store Sales

Most directly comparable IFRS financial measure: Retail sales from comparable base as a component of total Retail sales.

Definition: Prior year comparable store sales adjusted for published potash, nitrogen and phosphate benchmark prices and foreign exchange rates used in the current year. We retain sales of closed locations in the comparable base if the closed location is in close proximity to an existing location, unless we plan to exit the market area or are unable to economically or logistically serve it. We do not adjust for temporary closures, expansions or renovations of stores.

Why we use the measure and why it is useful to investors: To evaluate sales growth by adjusting for fluctuations in commodity prices and foreign exchange rates. Includes locations we have owned for more than 12 months.

 

         Twelve Months Ended December 31      

 (millions of US dollars, except as otherwise noted)

                           2021                             2020    

 Sales from comparable base

    

Prior period

     14,785       13,282    

Adjustments 1

     (476     -    

Revised prior period

     14,309       13,282    

Current period

     17,511       13,546    

 Comparable store sales (%)

     22       2    

 Prior period normalized for benchmark prices and foreign exchange rates

     16,350       12,784    

 Normalized comparable store sales (%)

     7       6    

1 Adjustments relate to prior period sales related to closed locations or businesses that no longer exist in the current period in order to provide a comparable base in our calculation.

 

Appendix C – Other Financial Measures

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by a company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of a company, (b) are not disclosed in the financial statements of the company, (c) are not non-IFRS financial measures, and (d) are not non-IFRS ratios.

The following section provides an explanation of the composition of those supplementary financial measures if not previously provided.

Retail adjusted EBITDA margin: Retail adjusted EBITDA divided by Retail sales for the last four rolling quarters.

Retail digital platform sales: Grower and employee sales in North America entered directly into the digital platform.

Retail digital platform sales to total sales: Grower and employee sales in North America entered directly into the digital platform as a percentage of total sales in North America.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Retail adjusted EBITDA per US selling location: Calculated as total Retail US adjusted EBITDA for the last four rolling quarters, representing the organic EBITDA component, which excludes acquisitions in those quarters, divided by the number of US locations that have generated sales in the last four rolling quarters, adjusted for acquired locations in those quarters.

 

21


Unaudited   In millions of US dollars except as otherwise noted  

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

                  Three Months Ended        
December 31
    Twelve Months Ended
December 31
 
     Note            2021       2020       2021       2020  

 SALES

   2      7,267       4,052       27,712       20,908  

 Freight, transportation and distribution

        198       202       851       855  

 Cost of goods sold

          3,863       2,685       17,452       14,814  

 GROSS MARGIN

        3,206       1,165       9,409       5,239  

 Selling expenses

        855       732       3,142       2,813  

 General and administrative expenses

        148       117       477       429  

 Provincial mining taxes

        173       41       466       204  

 Share-based compensation expense

        73       60       198       69  

 Impairment of assets

        21       1       33       824  

 Other expenses (income)

   3      109       (189     312       (2

 EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

     1,827       403       4,781       902  

 Finance costs

          246       119       613       520  

 EARNINGS BEFORE INCOME TAXES

        1,581       284       4,168       382  

 Income tax expense (recovery)

          374       (32     989       (77

 NET EARNINGS

          1,207       316       3,179       459  

 Attributable to

           

 Equity holders of Nutrien

        1,201       316       3,153       459  

 Non-controlling interest

          6       -       26       -  

 NET EARNINGS

          1,207       316       3,179       459  

 NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)

 

 Basic

        2.11       0.55       5.53       0.81  

 Diluted

          2.11       0.55       5.52       0.81  

 Weighted average shares outstanding for basic EPS

        568,027,000       569,180,000       569,664,000       569,657,000  

 Weighted average shares outstanding for diluted EPS

          569,653,000       569,393,000       571,289,000       569,686,000  

 

Condensed Consolidated Statements of Comprehensive Income

 

 

          Three Months Ended
December 31
    Twelve Months Ended
December 31
 

 (Net of related income taxes)

          2021       2020       2021       2020  

 NET EARNINGS

        1,207       316       3,179       459  

 Other comprehensive income

           

 Items that will not be reclassified to net earnings:

           

 Net actuarial gain on defined benefit plans

        95       72       95       75  

 Net fair value (loss) gain on investments

        (35     18       81       (7

 Items that have been or may be subsequently reclassified to

 net earnings:

           

 Gain (loss) on currency translation of foreign operations

        14       194       (115     142  

 Other

          (2     (4     17       (16

 OTHER COMPREHENSIVE INCOME

          72       280       78       194  

 COMPREHENSIVE INCOME

          1,279       596       3,257       653  

 Attributable to

           

 Equity holders of Nutrien

        1,273       596       3,232       653  

 Non-controlling interest

          6       -       25       -  

 COMPREHENSIVE INCOME

          1,279       596       3,257       653  

 (See Notes to the Condensed Consolidated Financial Statements)

 

 

22


Unaudited   In millions of US dollars except as otherwise noted  

 

Condensed Consolidated Statements of Cash Flows

 

       
Three Months Ended
December 31
 
 
   
Twelve Months Ended
December 31
 
 
            2021       2020       2021       2020  

  OPERATING ACTIVITIES

           

  Net earnings

        1,207       316       3,179       459  

  Adjustments for:

           

  Depreciation and amortization

        497       499       1,951       1,989  

  Share-based compensation expense

        73       60       198       69  

  Impairment of assets

        21       1       33       824  

  Loss on early extinguishment of debt

        142       -       142       -  

  Net gain on disposal of investment in Misr Fertilizers

  Production Company S.A.E. (“MOPCO”)

        -       (250     -       (250

  Provision for (recovery of) deferred income tax

        66       90       (31     (9

  Cloud computing transition adjustment

        -       -       36       -  

  Other long-term assets, liabilities and miscellaneous

          (3     (112     39       (333

  Cash from operations before working capital changes

        2,003       604       5,547       2,749  

  Changes in non-cash operating working capital:

           

  Receivables

        1,432       1,600       (1,669     145  

  Inventories

        (1,652     (1,068     (1,459     85  

  Prepaid expenses and other current assets

        (1,092     (946     (227     (10

  Payables and accrued charges

          2,946       2,588       1,694       354  

  CASH PROVIDED BY OPERATING ACTIVITIES

          3,637       2,778       3,886       3,323  

  INVESTING ACTIVITIES

           

  Capital expenditures 1

        (568     (535     (1,783     (1,549

  Business acquisitions, net of cash acquired

        (18     (17     (88     (233
  Proceeds from disposal of investment in MOPCO         -       540       -       540  

  Other

        121       17       64       38  

  CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES

          (465     5       (1,807     (1,204

  FINANCING ACTIVITIES

           

  Transaction costs related to debt

        -       -       (7     (15

  Proceeds from (repayment of) short-term debt, net

        307       (1,493     1,344       (892

  Proceeds from long-term debt

        (3     21       86       1,541  

  Repayment of long-term debt

        (2,207     (2     (2,212     (509

  Repayment of principal portion of lease liabilities

        (78     (71     (320     (274
  Dividends paid to Nutrien’s shareholders         (266     (259     (1,045     (1,030

  Repurchase of common shares

        (885     -       (1,035     (160

  Issuance of common shares

        12       -       200       -  

  Other

        -       -       (14     -  

  CASH USED IN FINANCING ACTIVITIES

          (3,120     (1,804     (3,003     (1,339

  EFFECT OF EXCHANGE RATE CHANGES ON CASH AND

    CASH EQUIVALENTS

          4       10       (31     3  

  INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

        56       989       (955     783  

  CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

     443       465       1,454       671  

  CASH AND CASH EQUIVALENTS – END OF PERIOD

          499       1,454       499       1,454  

  Cash and cash equivalents comprised of:

           

  Cash

        428       1,375       428       1,375  

  Short-term investments

          71       79       71       79  
            499       1,454       499       1,454  

  SUPPLEMENTAL CASH FLOWS INFORMATION

           

  Interest paid

        172       164       491       498  

  Income taxes paid

        79       64       435       156  

  Total cash outflow for leases

          94       79       393       345  

1 Includes additions to property, plant and equipment and intangible assets for the three months ended December 31, 2021 of $528 and $40 (2020 – $496 and $39), respectively, and for the twelve months ended December 31, 2021 of $1,676 and $107 (2020 – $1,423 and $126), respectively.

  (See Notes to the Condensed Consolidated Financial Statements)

 

23


Unaudited   In millions of US dollars except as otherwise noted  

 

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated Other Comprehensive
(Loss) Income (“AOCI”)
                         
     Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    Loss on
Currency
Translation
of Foreign
Operations
    Other     Total
AOCI
    Retained
Earnings
   

Equity
Holders

of

Nutrien
(Note 1)

    Non-
Controlling
Interest
(Note 1)
    Total
Equity
 
           

 BALANCE – DECEMBER 31, 2019

    572,942,809       15,771       248       (204     (47     (251     7,101       22,869       38       22,907  
           

 Net earnings

    -       -       -       -       -       -       459       459       -       459  
           

 Other comprehensive income

    -       -       -       142       52       194       -       194       -       194  
           

 Shares repurchased

    (3,832,580     (105     (55     -       -       -       -       (160     -       (160
           

 Dividends declared

    -       -       -       -       -       -       (1,029     (1,029     -       (1,029
           

 Effect of share-based compensation including issuance of common shares

    150,177       7       12       -       -       -       -       19       -       19  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       13       13       -       13       -       13  
           

 Transfer of net actuarial gain on defined benefit plans

    -       -       -       -       (75     (75     75       -       -       -  
           

 BALANCE – DECEMBER 31, 2020

    569,260,406       15,673       205       (62     (57     (119     6,606       22,365       38       22,403  
           

 BALANCE – DECEMBER 31, 2020

    569,260,406       15,673       205       (62     (57     (119     6,606       22,365       38       22,403  
           

 Net earnings

    -       -       -       -       -       -       3,153       3,153       26       3,179  
           

 Other comprehensive (loss) income

    -       -       -       (114     193       79       -       79       (1     78  
           

 Shares repurchased

    (15,982,154     (442     (47     -       -       -       (616     (1,105     -       (1,105
           

 Dividends declared

    -       -       -       -       -       -       (1,046     (1,046     -       (1,046
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (16     (16
           

 Effect of share-based compensation including issuance of common shares

    4,424,437       226       (9     -       -       -       -       217       -       217  
           

 Transfer of net gain on cash flow hedges

    -       -       -       -       (11     (11     -       (11     -       (11
           

 Transfer of net actuarial gain on defined benefit plans

    -       -       -       -       (95     (95     95       -       -       -  
           

 Share cancellation

    (210,173     -       -       -       -       -       -       -       -       -  
           

 BALANCE – DECEMBER 31, 2021

    557,492,516       15,457       149       (176     30       (146     8,192       23,652       47       23,699  

(See Notes to the Condensed Consolidated Financial Statements)

 

24


Unaudited   In millions of US dollars except as otherwise noted  

 

Condensed Consolidated Balance Sheets

 

     December 31            December 31  
 As at    2021            2020  
          Note 1  

 ASSETS

       

 Current assets

       

Cash and cash equivalents

     499          1,454  

Receivables

     5,366          3,626  

Inventories

     6,328          4,930  

Prepaid expenses and other current assets

     1,653          1,460  
     13,846          11,470  

 Non-current assets

       

Property, plant and equipment

     20,016          19,660  

Goodwill

     12,220          12,198  

Other intangible assets

     2,340          2,388  

Investments

     703          562  

Other assets

     829          914  

 TOTAL ASSETS

                     49,954                          47,192  

 LIABILITIES

       

 Current liabilities

       

Short-term debt

     1,560          159  

Current portion of long-term debt

     545          14  

Current portion of lease liabilities

     286          249  

Payables and accrued charges

     10,052          8,058  
     12,443          8,480  

 Non-current liabilities

       

Long-term debt

     7,521          10,047  

Lease liabilities

     934          891  

Deferred income tax liabilities

     3,165          3,149  

Pension and other post-retirement benefit liabilities

     419          454  

Asset retirement obligations and accrued environmental costs

     1,566          1,597  

Other non-current liabilities

     207          171  

 TOTAL LIABILITIES

     26,255          24,789  

 SHAREHOLDERS’ EQUITY

       

Share capital

     15,457          15,673  

Contributed surplus

     149          205  

Accumulated other comprehensive loss

     (146        (119

Retained earnings

     8,192          6,606  

Equity holders of Nutrien

     23,652          22,365  

Non-controlling interest

     47          38  

 TOTAL SHAREHOLDERS’ EQUITY

     23,699          22,403  

 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

     49,954          47,192  

 

 (See

Notes to the Condensed Consolidated Financial Statements)

 

25


Unaudited   In millions of US dollars except as otherwise noted  

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Twelve Months Ended December 31, 2021

NOTE 1  BASIS OF PRESENTATION

Nutrien Ltd. (collectively with its subsidiaries, known as “Nutrien”, “we”, “us”, “our” or “the Company”) is the world’s largest provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

Our accounting policies are in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. The accounting policies and methods of computation used in preparing these unaudited condensed consolidated financial statements are materially consistent with those used in the preparation of our 2020 annual consolidated financial statements. These unaudited condensed consolidated financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual consolidated financial statements and should be read in conjunction with our 2020 annual consolidated financial statements. Our 2021 annual consolidated financial statements, which are expected to be issued in February 2022, will include additional information under IFRS.

Certain immaterial 2020 figures have been reclassified in the condensed consolidated statements of changes in shareholders’ equity and condensed consolidated balance sheets.

In management’s opinion, the unaudited condensed consolidated financial statements include all adjustments necessary to fairly present such information in all material respects.

NOTE 2  SEGMENT INFORMATION

The Company has four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and it provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produce.

 

26


Unaudited   In millions of US dollars except as otherwise noted  

 

     Three Months Ended December 31, 2021  
      Retail       Potash      Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

     3,847        1,358        1,476       586       -       -       7,267  

             – intersegment

     31        128        292       65       -       (516     -  

 Sales   – total

     3,878        1,486        1,768       651       -       (516     7,267  

 Freight, transportation and distribution

     -        66        119       58       -       (45     198  

 Net sales

     3,878        1,420        1,649       593       -       (471     7,069  

 Cost of goods sold

     2,705        305        895       430       -       (472     3,863  

 Gross margin

     1,173        1,115        754       163       -       1       3,206  

 Selling expenses

     848        1        2       1       3       -       855  

 General and administrative expenses

     43        2        7       3       93       -       148  

 Provincial mining taxes

     -        173        -       -       -       -       173  

 Share-based compensation expense

     -        -        -       -       73       -       73  

 Impairment of assets

     -        -        17       4       -       -       21  

 Other expenses (income)

     20        3        (28     2       112       -       109  

 Earnings (loss) before finance costs and income taxes

     262        936        756       153       (281     1       1,827  

 Depreciation and amortization

     178        117        148       39       15       -       497  

 EBITDA  1

     440        1,053        904       192       (266     1       2,324  

 Integration and restructuring related costs

     2        -        -       -       (6     -       (4

 Share-based compensation expense

     -        -        -       -       73       -       73  

 Impairment of assets

     -        -        17       4       -       -       21  

 COVID-19 related expenses

     -        -        -       -       11       -       11  

 Foreign exchange loss, net of related derivatives

     -        -        -       -       38       -       38  

 Adjusted EBITDA

     442        1,053        921       196       (150     1       2,463  

 Assets – at December 31, 2021

     22,387        13,148        11,093       1,699       2,266       (639     49,954  

1  EBITDA is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 

     Three Months Ended December 31, 2020  
      Retail       Potash      Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

     2,608        467        647       318       12       -       4,052  

             – intersegment

     10        57        147       56       -       (270     -  

 Sales   – total

     2,618        524        794       374       12       (270     4,052  

 Freight, transportation and distribution

     -        74        125       54       -       (51     202  

 Net sales

     2,618        450        669       320       12       (219     3,850  

 Cost of goods sold

     1,733        305        557       304       11       (225     2,685  

 Gross margin

     885        145        112       16       1       6       1,165  

 Selling expenses

     727        2        8       2       (7     -       732  

 General and administrative expenses

     33        2        1       3       78       -       117  

 Provincial mining taxes

     -        40        -       -       1       -       41  

 Share-based compensation expense

     -        -        -       -       60       -       60  

 Impairment of assets

     -        1        -       -       -       -       1  

 Other expenses (income)

     8        4        (263     (13     75       -       (189

 Earnings (loss) before finance costs and income taxes

     117        96        366       24       (206     6       403  

 Depreciation and amortization

     180        123        146       39       11       -       499  

 EBITDA

     297        219        512       63       (195     6       902  

 Integration and restructuring related costs

     -        -        4       -       18       -       22  

 Share-based compensation expense

     -        -        -       -       60       -       60  

 Impairment of assets

     -        1        -       -       -       -       1  

 COVID-19 related expenses

     -        -        -       -       18       -       18  

 Foreign exchange loss, net of related derivatives

     -        -        -       -       15       -       15  

 Net gain on disposal of investment in
MOPCO

     -        -        (250     -       -       -       (250

 Adjusted EBITDA

     297        220        266       63       (84     6       768  

 Assets – at December 31, 2020 ¹

     20,526        12,032        10,612       1,462       2,983       (423     47,192  

1  In 2021, we reassessed the appropriate segment wherein certain assets related to transportation, distribution and logistics should be categorized. After our evaluation was complete, we determined the assets should be categorized in the Potash, Nitrogen and Phosphate segments.

 

 

27


Unaudited   In millions of US dollars except as otherwise noted  

 

     Twelve Months Ended December 31, 2021  
      Retail       Potash      Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

     17,665        4,021        4,216       1,810       -       -       27,712  

             – intersegment

     69        386        921       236       -       (1,612     -  

 Sales   – total

     17,734        4,407        5,137       2,046       -       (1,612     27,712  

 Freight, transportation and distribution

     -        371        448       217       -       (185     851  

 Net sales

     17,734        4,036        4,689       1,829       -       (1,427     26,861  

 Cost of goods sold

     13,134        1,285        2,963       1,408       -       (1,338     17,452  

 Gross margin

     4,600        2,751        1,726       421       -       (89     9,409  

 Selling expenses

     3,124        9        24       6       (21     -       3,142  

 General and administrative expenses

     168        8        15       11       275       -       477  

 Provincial mining taxes

     -        466        -       -       -       -       466  

 Share-based compensation expense

     -        -        -       -       198       -       198  

 Impairment of assets

     -        7        22       4       -       -       33  

 Other expenses (income)

     86        22        (64     15       253       -       312  

 Earnings (loss) before finance costs and income taxes

     1,222        2,239        1,729       385       (705     (89     4,781  

 Depreciation and amortization

     706        488        557       151       49       -       1,951  

 EBITDA

     1,928        2,727        2,286       536       (656     (89     6,732  

 Integration and restructuring related costs

     10        -        -       -       33       -       43  

 Share-based compensation expense

     -        -        -       -       198       -       198  

 Impairment of assets

     -        7        22       4       -       -       33  

 COVID-19 related expenses

     -        -        -       -       45       -       45  

 Foreign exchange loss, net of related derivatives

     -        -        -       -       39       -       39  

 Cloud computing transition adjustment

     1        2        -       -       33       -       36  

 Adjusted EBITDA

     1,939        2,736        2,308       540       (308     (89     7,126  

Assets – at December 31, 2021

     22,387        13,148        11,093       1,699       2,266       (639     49,954  
     Twelve Months Ended December 31, 2020  
      Retail       Potash      Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

     14,748        2,265        2,572       1,241       82       -       20,908  

             – intersegment

     37        248        628       202       -       (1,115     -  

 Sales   – total

     14,785        2,513        3,200       1,443       82       (1,115     20,908  

 Freight, transportation and distribution

     -        367        460       241       -       (213     855  

 Net sales

     14,785        2,146        2,740       1,202       82       (902     20,053  

 Cost of goods sold

     11,049        1,183        2,265       1,166       74       (923     14,814  

 Gross margin

     3,736        963        475       36       8       21       5,239  

 Selling expenses

     2,795        9        27       6       (24     -       2,813  

 General and administrative expenses

     135        7        8       10       269       -       429  

 Provincial mining taxes

     -        201        1       -       2       -       204  

 Share-based compensation expense

     -        -        -       -       69       -       69  

 Impairment of assets

     -        23        27       769       5       -       824  

 Other expenses (income)

     44        8        (288     6       228       -       (2

 Earnings (loss) before finance costs and income taxes

     762        715        700       (755     (541     21       902  

 Depreciation and amortization

     668        452        599       218       52       -       1,989  

 EBITDA

     1,430        1,167        1,299       (537     (489     21       2,891  

 Integration and restructuring related costs

     -        -        4       -       56       -       60  

 Share-based compensation expense

     -        -        -       -       69       -       69  

 Impairment of assets

     -        23        27       769       5       -       824  

 COVID-19 related expenses

     -        -        -       -       48       -       48  

 Foreign exchange loss, net of related derivatives

     -        -        -       -       19       -       19  

 Loss on disposal of business

     -        -        -       -       6       -       6  

 Net gain on disposal of investment in
MOPCO

     -        -        (250     -       -       -       (250

 Adjusted EBITDA

     1,430        1,190        1,080       232       (286     21       3,667  

 Assets – at December 31, 2020

     20,526        12,032        10,612       1,462       2,983       (423     47,192  

 

28


Unaudited   In millions of US dollars except as otherwise noted  

 

NOTE 3  OTHER EXPENSES (INCOME)

 

    

        Three Months Ended        

December 31

   

        Twelve Months Ended        

December 31

 
      2021     2020     2021     2020  

 Integration and restructuring related (recovery) costs

     (4     22       43       60  

 Foreign exchange loss, net of related derivatives

     38       17       42       18  

 Earnings of equity-accounted investees

     (46     (27     (89     (73

 Bad debt expense (recovery)

     4       (3     26       6  

 COVID-19 related expenses

     11       18       45       48  

 Loss on disposal of business

     -       -       -       6  

 Net gain on disposal of investment in MOPCO

     -       (250     -       (250

 Cloud computing transition adjustment

     -       -       36       -  

 Other expenses

                 106       34       209                 183  
       109       (189                 312       (2

In the fourth quarter of 2020, as a result of our strategic decision to dispose of our investment in MOPCO, we received cash consideration of $540 for the disposal of the investment and settlement of legal claims. This resulted in a pre-tax gain of $250 recorded in other (income) expenses.

 

NOTE 4  SHARE CAPITAL

 

Share Repurchase Programs

 

 

 

 

             Three Months Ended        
December  31
            Twelve Months Ended        
December 31
 
      2021                     2020     2021     2020  

 Number of common shares repurchased for cancellation

     13,522,057       -       15,982,154       3,832,580  

 Average price per share (US dollars)

     70.64       -       69.17       41.96  

 Total cost

     955             -       1,105       160  

As of February 15, 2022, an additional 6,204,241 common shares were repurchased for cancellation at a cost of $445 and an average price per share of $71.70.

On February 16, 2022, our Board of Directors approved a share repurchase program of up to a maximum of 10 percent of our outstanding common shares for cancellation. Subject to the acceptance by the Toronto Stock Exchange, the 2022 normal course issuer bid (“NCIB”) will commence following the expiration of our current NCIB on February 28, 2022 and will expire after a one-year period.

Dividends Declared

On February 16, 2022, our Board of Directors declared an increase to our quarterly dividend to $0.48 per share payable on April 14, 2022, to shareholders of record on March 31, 2022. The total estimated dividend to be paid is $265.

 

29